Culture medium for stomach cancer organs and culture method
A culture medium and organoid technology, applied in the field of biomedicine, can solve the problems of less research and reports on gastric cancer tumor organoid culture methods, and few reports on the formulation of organoid culture medium, so as to reduce the risk of microbial contamination and reduce cell Toxicity and inhibitors, cost-saving effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] This embodiment provides a culture medium for gastric cancer organoids, including basal medium 1640, specific additive factors and sterile water; wherein, the mass ratio of the basal medium 1640 to the sterile water is: 99:1 The specific addition factors include: vitamin A-free B27, 1×; N-acetylcysteine, 2 μM; EGF, 50ng / ml; Noggin, 200ng / ml; R-spondin 1, 200ng / ml; Wnt3a, 100ng / ml ml; CHIR99021, 5μM; thiazovivin, 2μM; Gastrin I, 20ng / ml; The concentration of each component of the additive factor is based on its concentration in the mixture of basal medium 1640 and sterile water.
Embodiment 2
[0040] This embodiment provides a culture medium for gastric cancer organoids, including basal medium 1640, specific additive factors and sterile water; wherein, the mass ratio of the basal medium 1640 to the sterile water is: 99:1 The specific addition factors include: vitamin A-free B27, 2×; N-acetylcysteine, 1 μM; EGF, 80ng / ml; Noggin, 150ng / ml; R-spondin 1, 400ng / ml; Wnt3a, 150ng / ml ml; CHIR99021, 5μM; thiazovivin, 2μM; Gastrin I, 25ng / ml; The concentration of each component of the additive factor is based on its concentration in the mixture of basal medium and sterile water.
Embodiment 3
[0042]This embodiment provides a culture medium for gastric cancer organoids, including basal medium 1640, specific additive factors and sterile water; wherein, the mass ratio of the basal medium 1640 to the sterile water is: 99:1 The specific addition factors include: vitamin A-free B27, 1.5×; N-acetylcysteine, 4.5 μM; EGF, 80ng / ml; Noggin, 250ng / ml; R-spondin 1, 150ng / ml; Wnt3a, 150ng / ml; CHIR99021, 2.5μM; thiazovivin, 2.5μM; Gastrin I, 40ng / ml; Valproic acid, 1.5mM; penicillin-streptomycin mixed solution, 2×; mg / ml; the concentration of each component of the above-mentioned specific addition factor is based on its concentration in the mixture of basal medium and sterile water.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com